BONESUPPORT Announces CE-mark And Launch Of CERAMENT™|G The First Injectable Gentamicin Eluting Bone Substitute To Promote And Protect Bone Healing In Osteomyelitis (via PR Newswire)
LUND, Sweden, Feb. 13, 2013 /PRNewswire/ — BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today that the next generation product of the CERAMENT™ family, CERAMENT™|G has…
published: February 14, 2013 in: Approval/Clearance, Orthopaedics